Coagulation Disorder, Sepsis
Conditions
Keywords
sepsis, coagulation disorders
Brief summary
The study was a retrospective, single-center clinical study. From all patients admitted to the emergency ICU during the period of 2013.1.1-2019.12.31, the investigators screened all patients who met the criteria of 1) ≤7 days from symptom onset to enrollment; 2) patients who also met the criteria of the presence of clinical infections and Sequential Organ Failure Assessment (SOFA) score ≥2; and 3) met the exclusion criteria, and retrospectively collected coagulation indices of the patients before anticoagulation with or without the use of heparin or low molecular heparin, and recorded the worst values of coagulation function of patients before heparin were recorded, and the organ function, inflammatory response, immune indexes, and conversion rate of severe disease were observed, so as to investigate the role of conventional coagulation indexes (FDP, D-dimer) and thromboelastography in the early diagnosis of septicemia patients and to indicate the prognosis.
Interventions
DIAGNOSTIC_TESTEarly general coagulation function (5 items of coagulation) and thromboelastogram monitoring
* Correlation analysis of sepsis severity with FDP and D-Dimer * Discussion on the critical value and area under the curve of FDP and D-Dimer in diagnosis of sepsis * Differences in age and sex of FDP and D-Dimer in diagnosis of sepsis * Effect of FDP and D-Dimer diagnosis of sepsis on severe conversion rate and all-cause mortality of patients * The difference of thromboelastogram in patients with sepsis of different severity * Thromboelastogram items (R time α Correlation between angle, k time, maximum blood clot strength and comprehensive coagulation index) and sepsis
Sponsors
Ruijin Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Inclusion criteria
* Time from clinical symptoms to admission ≤ 7 days； * infection was diagnosed by clinician * Systemic inflammatory response syndrome，Systemic inflammatory response syndrome was defined as the presence of 2 or more of the following: (1) temperature \<36℃or \>38℃, (2) heart rate \>90 beats per minute, (3) respiratory rate \>20 breaths per minute or PaCO2 \< 32 mm Hg, or (4) white blood cell count ≥12 000 cells/mm3 or≤4000 cells/mm
Exclusion criteria
* Pregnancy and lactation * Have hematological diseases (including acute and chronic leukemia, hemolytic anemia, hemophilia, aplastic anemia, bone marrow fibrosis, congenital or acquired coagulation factor deficiency, etc.) * Anticoagulant or antiplatelet drug treatment * 24 hours after severe trauma or surgery * Autoimmune diseases * cirrhosis * Malignant tumor patients with personal history or undergoing radiotherapy, chemotherapy and targeted treatment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The plasma concentration of fibrin degradation products(FDP) in ug/ml | within 3 days of admission before the use of anticoagulant drugs | The plasma concentration of fibrin degradation products(FDP) was assessed after the participant was enrolled within 3 days of admission before the use of anticoagulant drugs |
| The plasma concentration of DDimer in ug/ml | within 3 days of admission before the use of anticoagulant drugs | The plasma concentration of DDimer was assessed after the participant was enrolled within 3 days of admission before the use of anticoagulant drugs |
Countries
China
Contacts
Primary Contactpeili CHEN, MD
Backup ContactEnqiang MAO, PhD
Outcome results
None listed